Nurix Therapeutics offers promising targeted protein degradation treatments for cancer and autoimmune diseases. Find out what ...

Among the large drugmakers, Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer are worth retaining in one’s portfolio.

Sanofi India Limited (Previously known as Aventis Pharma Limited ... Results of the Company for the quarter and nine months ended 30th September 2024 to the stock exchanges. The Company has approved ...

Having a diversified portfolio is pretty much Investing 101, right? I mean, it’s one of the first things we all learn as ...

Recursion has partnered with several healthcare giants, such as Bayer (BAYZF) and Sanofi (SNY). These collaborations ... The average 12-month target price for RXRX stock is $10.14, indicating an ...

Activist investor Starboard Value's $1 billion stake in Pfizer may not address the company's underlying growth ...

The Indian pharmaceutical sector faces mixed growth with a 12% YoY and 5% QoQ rise while IPM growth is projected at 8%. Companies like Dr. Reddy's, Zy ...

Amid the stock market frenzy surrounding weight-loss medicines, one Belgian biotech company is rewarding investors by ...

Further dampening sentiment on Monday was an order from a U.S. judge for market heavyweight Alphabet's Google to overhaul its ...

SoFi Technologies, Inc. (NASDAQ:SOFI) shares are trading higher on Tuesday and the stock is up more than 20% over the past ...

Wall Street’s benchmark index dropped almost 1 per cent to finish at 5,695, the lowest level since September 19. The technology-heavy Nasdaq Composite dropped 1.2 per cent.